RT Journal Article
SR Electronic
T1 PC.77 Sedation and analgesia for neonates in NICUs across the United Kingdom: The Europain survey
JF Archives of Disease in Childhood - Fetal and Neonatal Edition
JO Arch Dis Child Fetal Neonatal Ed
FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
SP A62
OP A62
DO 10.1136/archdischild-2014-306576.178
VO 99
IS Suppl 1
A1 R Carbajal
A1 E Courtois
A1 M Eriksson
A1 H Lagercrantz
A1 EM Boyle
YR 2014
UL http://fn.bmj.com/content/99/Suppl_1/A62.2.abstract
AB Background Pain and stress induced by mechanical ventilation, invasive procedures, or painful diseases supports the use of sedation/analgesia (S/A) in newborns admitted to Neonatal Units (NNUs). To date, these practices have not been studied on a large scale. Objective To determine current clinical practices regarding the use of S/A drugs in NNUs across the United Kingdom (UK). Design/Methods A European epidemiological observational study on clinical practices regarding bedside use of S/A collected data for all neonates in participating NNUs until the infant left the unit (discharge, death, transfer) or for up to 28 days. Data collection occurred via an online database for 1 month at each NNU. Neonates up to 44 weeks gestation were included. Results From February 2013 to May 2013, 66 UK NNUs collected data on 2691 eligible neonates. Of these, 713 received tracheal ventilation and 1978 had spontaneous breathing or non-invasive ventilation. The median (IQR) gestational age of ventilated neonates [32.1 (27.9–38.6)] was lower than for non-ventilated neonates [37.0 (34.1–39.7), p < 0.001]. Overall, more ventilated neonates [83.0% (n = 592)] received S/A drugs than non-ventilated neonates [7.4% (n = 147); p < 0.001]. The table shows S/A drugs used in ventilated neonates. View this table:Abstract PC.77 Table Conclusions Most ventilated but few non-ventilated neonates receive S/A therapy in UK NNUs. Wide variations in rates of S/A use and drugs used exist among centres.